News Headlines Article

East Bay medical device company targets $115 million IPO
San Francisco Business Times

A quietly booming Alameda medical device developer wants to use a $115 million initial public offering to boost its product offerings, research and sales force. Penumbra Inc. is that latest in a string of Bay Area life sciences IPOs, but its steady stream of revenue from catheters and coils that treat strokes, aneurysms and other vascular conditions make it a rarity. Most drug developers have longer timelines for bringing drugs to market, but med device development can move much more quickly.